Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/06/2025 ,inter alia, to consider and approve Submission of Prior ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) has informed BSE about a Board Meeting scheduled for Tuesday, 24th June 2025 at its registered office in Hyderabad. The key agenda item is to consider and approve the conversion of warrants into equity shares of the company. Any other matter with the permission of the chair may also be taken up. The intimation is filed under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing is signed by Whole-time Director Venkateshwarlu Pulluru (DIN: 02076871).
If approved, conversion of warrants into equity shares will increase the company's share capital, leading to dilution of existing shareholders' holdings. Investors should watch for the outcome of the board meeting on 24th June for clarity on the number of shares being issued and the resultant dilution impact.